BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 8211211)

  • 1. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
    Helleberg C; Taaning EB; Johnsen HE
    Ugeskr Laeger; 1995 Sep; 157(37):5082-6. PubMed ID: 7502374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients refractory to platelet transfusion.
    Chockalingam P; Sacher RA
    J Infus Nurs; 2007; 30(4):220-5. PubMed ID: 17667077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet transfusion. Current techniques, remaining problems, and future prospects.
    Herman JH; Kamel HT
    Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mini-review on platelet refractoriness.
    Rebulla P
    Haematologica; 2005 Feb; 90(2):247-53. PubMed ID: 15710579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of platelets and other transfusion products in patients with malignancy.
    Bayer WL; Bodensteiner DC; Tilzer LL; Adams ME
    Semin Thromb Hemost; 1992; 18(4):380-91. PubMed ID: 1470926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of refractoriness to platelet transfusion.
    Schiffer CA
    Blood Rev; 2001 Dec; 15(4):175-80. PubMed ID: 11792118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of platelets in transfusion medicine.
    Brubaker DB
    J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
    Apelseth TO; Hervig T; Bruserud O
    Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransfusion purpura following bone marrow transplantation.
    Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
    Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):291-311. PubMed ID: 2179213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alloimmunized patient: effective transfusion support and newer experimental approaches.
    Pamphilon DH
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):651-4. PubMed ID: 1450334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.